Arcturus Therapeutics Holdings (ARCT) Change in Account Payables (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Change in Account Payables data on file, last reported at -$142000.0 in Q1 2026.

• Quarterly Change in Account Payables rose 86.01% year-over-year to -$142000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 29.65% YoY) and the FY2025 annual result came in at -$3.0 million, down 254.52% from the prior year.
• Change in Account Payables advanced to -$142000.0 in Q1 2026, from -$1.3 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $11.8 million in Q1 2023 to a low of -$12.7 million in Q4 2023.
• A 5-year average of -$384470.6 and a median of -$1.0 million in 2025 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables sank 569.28% — and 2023, when it surged 26890.91%.
• Tracing ARCT's Change in Account Payables over 5 years: stood at -$8.4 million in 2022, then tumbled by 50.76% to -$12.7 million in 2023, then jumped by 76.94% to -$2.9 million in 2024, then jumped by 54.27% to -$1.3 million in 2025, then surged by 89.43% to -$142000.0 in 2026.
• The last three Change in Account Payables figures came in at -$142000.0 (Q1 2026), -$1.3 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.